As per a new, comprehensive report from Arizton research, the Canada point-of-care molecular diagnostics market size was valued at USD 350 million in 2024 and is expected to reach USD 560 million by 2030, growing at a CAGR of 8.15% during the forecast period.
Explore the Full Market Insights: https://www.arizton.com/market-reports/canada-point-of-care-molecular-diagnostics-market
Report Summary:
Market Size (2030): USD 560 Million
Market Size (2024): USD 350 Million
CAGR (2024-2030): 8.15%.
Historic Year: 2021-2023
Base Year: 2024
Forecast Year: 2025-2030
Market Segmentation: Diagnostic, Assay Format, Application Area, and End User
Regional Analysis: Ontario, Quebec, British Columbia, Alberta, Atlantic Provinces, Northern Territories, and Others
Canada’s Healthcare Efficiency Gets a Boost: POC Molecular Diagnostics Lead the Way
Canada’s point-of-care (POC) molecular diagnostics market is witnessing strong momentum in 2025, driven by the growing demand for faster, more accessible testing solutions. By enabling rapid, lab-quality diagnostics directly at the patient’s location, POC molecular tools are transforming how healthcare providers deliver timely care. Their adoption in emergency settings, particularly for conditions such as acute myocardial infarction, has proven effective in reducing diagnostic delays, lowering hospital admissions, and easing the strain on healthcare systems.The expansion of POC testing beyond hospitals, into clinics, pharmacies, and remote care settings, is further driving healthcare accessibility and supporting a shift toward decentralized, patient-centric care models. Supported by advancements in molecular technologies and government initiatives, Canada’s adoption of rapid diagnostics underscores a broader movement toward improved healthcare efficiency, outcome-driven delivery, and equitable access across the nation.
Canada’s POC Molecular Diagnostics Market Surges Amid Infectious Disease Challenges
The Canadian point-of-care (POC) molecular diagnostics market is gaining critical importance as the country faces a resurgence of infectious diseases, including measles, respiratory viruses, and foodborne illnesses. These outbreaks have highlighted the urgent need for rapid, accurate, and decentralized testing solutions to support timely interventions and effective containment. Since October 2024, Ontario has reported over 2,000 measles cases, surpassing the total reported cases in the US for 2025, primarily affecting unvaccinated children and leading to hospitalizations. POC molecular diagnostics have proven indispensable in enabling early detection, reducing transmission, and supporting rapid clinical decision-making across clinics, community centers, and schools.
Similarly, the May 2025 Salmonella outbreak impacted multiple provinces, causing hospitalizations. The quick deployment of POC molecular testing facilitated fast detection and an immediate public health response, underscoring its role in strengthening Canada’s healthcare system, improving patient outcomes, and driving growth in the POC diagnostics market.
Smart Diagnostics Transform Canada’s Healthcare Market with AI and POC Innovations
The Canadian point-of-care (POC) molecular diagnostics market is rapidly transforming healthcare delivery through AI, microfluidics, and multiplex testing technologies. AI-driven platforms accelerate result interpretation, reduce human error, and enable faster clinical decisions for conditions ranging from cancer to infectious diseases. Portable and miniaturized diagnostic devices are bringing molecular testing to the bedside, clinics, and remote communities, expanding access beyond traditional laboratories. Multiplex testing enhances efficiency by detecting multiple pathogens from a single sample, supporting rapid outbreak response and disease management. Meanwhile, the rise of at-home molecular diagnostics is creating new market opportunities, giving Canadians convenient, private, and timely testing options. Together, these innovations are positioning the market to deliver scalable, patient-centric solutions and improved healthcare system efficiency nationwide.
Canada’s Rapid Testing Market Surges Through Strategic Regional Adoption
Ontario and Quebec are at the forefront of Canada’s point-of-care (POC) molecular diagnostics market, driving rapid adoption of technologies that detect viruses and bacteria quickly and accurately. Ontario’s dense network of hospitals, research centers, and high patient volumes has made it a hub for integrating POC devices into emergency departments, clinics, and long-term care facilities, with systems like GeneXpert connecting results directly to patient records for real-time monitoring.
Meanwhile, Quebec is expanding adoption through research-focused hospitals and emerging biotech clusters, extending rapid testing beyond major cities. Together, these regional developments are not only enhancing patient outcomes but also strengthening Canada’s healthcare efficiency, highlighting significant growth and strategic opportunities in the POC molecular diagnostics market.
Request a Sample Copy: https://www.arizton.com/market-reports/canada-point-of-care-molecular-diagnostics-market
Key Company Profiles
- Roche Diagnostics Canada
- Abbott Laboratories
- BioMérieux
- Becton Dickinson and Company (BD)
- QIAGEN
- Cepheid
- Hologic
- Thermo Fisher Scientific
- DiaSorin S.p.A.
Other Prominent Company Profiles
- Bioscience Inc.
- MedMira Inc.
- Bio-Rad Laboratories
- Agilent Technologies
- Illumina, Inc
- Grifols, S.A.
- Siemens Healthineers
- Sysmex Corporation
- LifeLabs
- SQI Diagnostics Inc
Market Segmentation & Forecast By
Diagnostic
- Nucleic Acid Amplification Tests
- Microfluidics and Lab-on-a-Chip Technologies
- CRISPR-based Molecular POC
- Others
Nucleic Acid Amplification-Based POC
- RT-PCR-based Molecular POC
- Loop-mediated Isothermal Amplification
Assay Format
- Simplex Assays
- Duplex Panels
- Triplex Panels
- Multiplex/Syndromic Panels
Application Area
- Respiratory infections
- Sexually transmitted infections (STIs & HIV)
- Tuberculosis (TB) diagnostics
- Bloodstream infections (BSI)
- Hepatitis B & C diagnostics
- Urinary tract infections (UTIs)
- Gastroenteric infections
- Blood yeast (fungal BSI) diagnostics
- Infectious Diseases Testing
- Others
End User
- Hospitals and Health Systems
- Clinical Laboratories
- Physician Offices and Outpatient Clinics
- Urgent Care and Walk-in Clinics
- Long-Term Care Facilities
- Remote and Rural Healthcare Settings
- Public Health Laboratories
- Others
Geography
- Canada
- Ontario
- Quebec
- British Columbia
- Alberta
- Atlantic Provinces
- Northern Territories
- Others
Related Reports That May Align with Your Business Needs
Global Telehealth Kiosk Market - Focused Insights 2024-2029
https://www.arizton.com/market-reports/telehealth-kiosk-market
U.S. Tele-Intensive Care Unit Market - Focused Insights 2024-2029
https://www.arizton.com/market-reports/us-tele-intensive-care-unit-icu-market
What Key Findings Will Our Research Analysis Reveal?
- How big is the Canada point-of-care molecular diagnostics market?
- What is the growth rate of the Canada point-of-care molecular diagnostics market?
- What are the key trends in the Canada point-of-care molecular diagnostics market?
- Who are the major players in the Canada point-of-care molecular diagnostics market?
- Which region dominates the Canada point-of-care molecular diagnostics market?
Why Arizton?
100% Customer Satisfaction
24x7 availability – we are always there when you need us
200+ Fortune 500 Companies trust Arizton's report
80% of our reports are exclusive and first in the industry
100% more data and analysis
1500+ reports published till date
Post-Purchase Benefit
- 1hr of free analyst discussion
- 10% off on customization
About Us:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/canada-point-of-care-molecular-diagnostics-market
